✦ LIBER ✦

A placebo-controlled trial of selegiline (l-deprenyl) in the treatment of tardive dyskinesia

✍ Scribed by Donald C. Goff; Perry F. Renshaw; Ofra Sarid-Segal; Daniel A. Dreyfuss; Edward T. Amico; Domenic A. Ciraulo

Book ID: 118856324
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 783 KB
Volume: 33
Category: Article
ISSN: 0006-3223
DOI: 10.1016/0006-3223(93)90119-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A placebo-controlled trial of valproate

A placebo-controlled trial of valproate in tardive dyskinesia

✍ Henry A. Nasrallah; Frederick J. Dunner; Mona McCalley-Whitters 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 244 KB

The effects of eicosapentaenoic acid in

The effects of eicosapentaenoic acid in tardive dyskinesia: A randomized, placebo-controlled trial

✍ Robin Emsley; Dana J.H. Niehaus; Liezl Koen; Piet P. Oosthuizen; H. Jadri Turner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Ineffectiveness of deanol in tardive dys

Ineffectiveness of deanol in tardive dyskinesia: A placebo controlled study

✍ C. Montigny; G. Chouinard; L. Annable 📂 Article 📅 1979 🏛 Springer 🌐 English ⚖ 536 KB

In a double-blind placebo-controlled study, deanol acetamidobenzoate, administered in doses up to 1.5 g q.d. for three weeks to chronic schizophrenic patients presenting moderate to severe tardive dyskinesia, failed to alleviate the dyskinetic movements. However, there was a tendency for a significa

Treatment of tardive dyskinesia with cer

Treatment of tardive dyskinesia with ceruletide: A double-blind, placebo-controlled study

✍ Takuya Kojima; Toshio Yamauchi; Matsue Miyasaka; Yoshifumi Koshino; Yoshibumi Na 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 481 KB

Selegiline in the treatment of akathisia

Selegiline in the treatment of akathisia, tardive dyskinesia, and negative schizophrenic symptoms

✍ Ames, D.; Wirshing, W.C.; Lee, M.A.; Cummings, J.L.; Putten, T.Van; Marder, S.R. 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Low-dose pergolide in the treatment of t

Low-dose pergolide in the treatment of tardive dyskinesia (TD): A double-blind, placebo-controlled randomized cross-over trial

✍ A. Diehl; H.P. Hundemer; M. Rubin; R.W. Dittmann; W. Gattaz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 129 KB